Freenome’s Licensing Agreement with Exact Sciences to Introduce a New Test for Colorectal Cancer Announcement Freenome, a leading biotechnology company developing an early cancer detection platform, has entered a licensing agreement with Exact Sciences to elevate its marketization of its...
AI’s support to pharma companies to handle policy pressures Announcement The previous experience, spanning years and months, created a regulatory storm for the biopharma industry. Companies have largely obeyed executive orders this year. The tariff policies and the Inflation Reduction Ac...
Porosome’s findings discovered an advancement, transforming AD research and treatment Announcement Porosome Therapeutics introduced major advancements in its excellent disease-modifying neurological platform. The new advancement will transition alzheimer’s disease (AD) treatment and...
Ambulatory Neurosurgery Center and UB Neurosurgery Partnered with NOVA Neuro Announcement The neuroscience and neurotechnology universities at Buffalo Neurosurgery (UBNS) and ANSC received $144,500 award to launch worldwide’s first-ever multi-omics research initiative focusing on forecas...
Big Pharma, a New Fame and Hero to Chinese Companies By Changing Time and Circumstances The out-licensing of drugs to multinational corporations is a general initiative by Chinese biotechs, but the rising deals are only looking for ready biotech partnerships in the area. The multinational phar...
Cyagen and Taconic Partnered to Receive Permission for Preclinical Studies of Mouse and Rat Models Announcement Cyagen Biosciences, a leading AI-powered CRO company, a pioneer in cell models for research, and custom genetically engineered animals, collaborated with Taconic Biosciences, a well-...
Noom’s New Microdose GLP-1 Program Aims to Tackle Obesity Announcement The Noom, a well-established digital healthcare company focused on chronic disease prevention and encouraging people to live a quality and longer life, launched the Noom microdose GLP-1program, a commendable initiati...
Solving the Commercial Puzzle to Succeed in Cell and Gene Therapies This Year's Challenges to CGT This year witnessed two leading examples of the challenges faced by the cell and gene therapy space, named Bluebird Bio and Sarepta Therapeutics. The two leaders, despite having products on the ma...
Fresenius and Polpharma Entered a Licensing Contract for the Proposed Vedolizumab Biosimilar PB016 Announcement Polpharma Biologics SA, a leading biotechnology company, signed a licensing agreement with Fresenius Kabi for marketing PB016 worldwide except North Africa and the Middle East. PB016...
Kuros Biosciences' New MagnetOs MIS Delivery System Announcement Kuros Biosciences, a known innovator of biologic technologies, completed its first-ever US international case with its new magnetos MIS delivery system. A system features, prefilled, sterile, and single-use delivery system helpfu...
